Filter by: patients
What is Hyoscyamine Sulfate?

Hyoscyamine Sulfate is an anticholinergic agent. It is used to treat peptic ulcers, irritable bowel, neurogenic bladder or bowel, infant colic, GI spasms, and to reduce rgidity, tremors and excessive sweating and salivation associated with parkinsonism, pancreatitis and heart block.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Bowel irritability 4 1 Efficacy_slight
Mucus in throat 1 1 Efficacy_moderate

See all 3 patients currently taking Hyoscyamine Sulfate

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
1
Moderate
0
Mild
0
None
1

Commonly reported side effects, conditions, and hospitalizations associated with Hyoscyamine Sulfate

Dry mouth (xerostomia) 1

Reported Dosages

  0.125mg as needed 0.125 mg daily 1 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Hyoscyamine Sulfate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 50%
Other 1   Other: 50%

See all 2 patients who’ve stopped taking Hyoscyamine Sulfate

Currently Taking Hyoscyamine Sulfate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Hyoscyamine Sulfate

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Hyoscyamine Sulfate

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Hyoscyamine Sulfate

Very
0 0%
Somewhat
0 0%
A little
1 50%
Not at all
1 50%

Cost

Paid out of pocket

Cost of Hyoscyamine Sulfate

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

Report created on May 25, 2012.